BROENNIMAN EDWARD G 4
4 · AETHLON MEDICAL INC · Filed Apr 1, 2026
Research Summary
AI-generated summary of this filing
Aethlon Medical Director Edward Broenniman Forfeits 89 Shares
What Happened
Edward G. Broenniman, a director of Aethlon Medical (AEMD), had 357 vested restricted stock units (RSUs) converted to common shares on 2026-03-31 and forfeited 89 of those shares to satisfy tax withholding obligations. The withheld shares were valued at $2.19 each, totaling approximately $195. This was a tax-withholding forfeiture (transaction code F), not an open-market sale or purchase.
Key Details
- Transaction date: 2026-03-31; reporting (filed) date: 2026-04-01. No late filing flag indicated.
- Withheld/forfeited: 89 shares at $2.19 per share; total value ≈ $195.
- Underlying award: conversion of 357 vested RSUs (per footnote referencing a grant reported on Form 4 filed 2025-04-25).
- Shares owned after the transaction: not specified in the provided filing.
- Transaction code F = tax withholding (shares withheld to cover tax liability).
Context
This was a routine tax-withholding action tied to RSU vesting (a common administrative event), not a directional buy or sell intended to signal sentiment. For retail investors, forfeitures for tax withholding generally do not indicate insider confidence or concern about the company’s prospects.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-03-31$2.19/sh−89$195→ 1,915 total
Footnotes (1)
- [F1]The Reporting Person forfeited 89 shares of common stock upon conversion of an aggregate 357 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.